Cargando…

Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies

This study investigates the development of topically applied non-invasive amino-functionalized silica nanoparticles (AMSN) and O-Carboxymethyl chitosan-coated AMSN (AMSN-CMC) for ocular delivery of 5-Fluorouracil (5-FU). Particle characterization was performed by the DLS technique (Zeta-Sizer), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhowyan, Adel Ali, Kalam, Mohd Abul, Iqbal, Muzaffar, Raish, Mohammad, El-Toni, Ahmed M., Alkholief, Musaed, Almomen, Aliyah A., Alshamsan, Aws
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920178/
https://www.ncbi.nlm.nih.gov/pubmed/36770926
http://dx.doi.org/10.3390/molecules28031260
_version_ 1784887006590926848
author Alhowyan, Adel Ali
Kalam, Mohd Abul
Iqbal, Muzaffar
Raish, Mohammad
El-Toni, Ahmed M.
Alkholief, Musaed
Almomen, Aliyah A.
Alshamsan, Aws
author_facet Alhowyan, Adel Ali
Kalam, Mohd Abul
Iqbal, Muzaffar
Raish, Mohammad
El-Toni, Ahmed M.
Alkholief, Musaed
Almomen, Aliyah A.
Alshamsan, Aws
author_sort Alhowyan, Adel Ali
collection PubMed
description This study investigates the development of topically applied non-invasive amino-functionalized silica nanoparticles (AMSN) and O-Carboxymethyl chitosan-coated AMSN (AMSN-CMC) for ocular delivery of 5-Fluorouracil (5-FU). Particle characterization was performed by the DLS technique (Zeta-Sizer), and structural morphology was examined by SEM and TEM. The drug encapsulation and loading were determined by the indirect method using HPLC. Physicochemical characterizations were performed by NMR, TGA, FTIR, and PXRD. In vitro release was conducted through a dialysis membrane in PBS (pH 7.4) using modified Vertical Franz diffusion cells. The mucoadhesion ability of the prepared nanoparticles was tested using the particle method by evaluating the change in zeta potential. The transcorneal permeabilities of 5-FU from AMNS-FU and AMSN-CMC-FU gel formulations were estimated through excised goat cornea and compared to that of 5-FU gel formulation. Eye irritation and ocular pharmacokinetic studies from gel formulations were evaluated in rabbit eyes. The optimum formulation of AMSN-CMC-FU was found to be nanoparticles with a particle size of 249.4 nm with a polydispersity of 0.429, encapsulation efficiency of 25.8 ± 5.8%, and drug loading capacity of 5.2 ± 1.2%. NMR spectra confirmed the coating of AMSN with the CMC layer. In addition, TGA, FTIR, and PXRD confirmed the drug loading inside the AMSN-CMC. Release profiles showed 100% of the drug was released from the 5-FU gel within 4 h, while AMSN-FU gel released 20.8% of the drug and AMSN-CMC-FU gel released around 55.6% after 4 h. AMSN-CMC-FU initially exhibited a 2.45-fold increase in transcorneal flux and apparent permeation of 5-FU compared to 5-FU gel, indicating a better corneal permeation. Higher bioavailability of AMSN-FU and AMSN-CMC-FU gel formulations was found compared to 5-FU gel in the ocular pharmacokinetic study with superior pharmacokinetics parameters of AMSN-CMC-FU gel. AMSN-CMC-FU showed 1.52- and 6.14-fold higher AUC0-inf in comparison to AMSN-FU and 5-FU gel, respectively. AMSN-CMC-FU gel and AMSN-FU gel were “minimally irritating” to rabbit eyes but showed minimal eye irritation potency in comparison to the 5 FU gel. Thus, the 5-FU loaded in AMSN-CMC gel could be used as a topical formulation for the treatment of ocular cancer.
format Online
Article
Text
id pubmed-9920178
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99201782023-02-12 Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies Alhowyan, Adel Ali Kalam, Mohd Abul Iqbal, Muzaffar Raish, Mohammad El-Toni, Ahmed M. Alkholief, Musaed Almomen, Aliyah A. Alshamsan, Aws Molecules Article This study investigates the development of topically applied non-invasive amino-functionalized silica nanoparticles (AMSN) and O-Carboxymethyl chitosan-coated AMSN (AMSN-CMC) for ocular delivery of 5-Fluorouracil (5-FU). Particle characterization was performed by the DLS technique (Zeta-Sizer), and structural morphology was examined by SEM and TEM. The drug encapsulation and loading were determined by the indirect method using HPLC. Physicochemical characterizations were performed by NMR, TGA, FTIR, and PXRD. In vitro release was conducted through a dialysis membrane in PBS (pH 7.4) using modified Vertical Franz diffusion cells. The mucoadhesion ability of the prepared nanoparticles was tested using the particle method by evaluating the change in zeta potential. The transcorneal permeabilities of 5-FU from AMNS-FU and AMSN-CMC-FU gel formulations were estimated through excised goat cornea and compared to that of 5-FU gel formulation. Eye irritation and ocular pharmacokinetic studies from gel formulations were evaluated in rabbit eyes. The optimum formulation of AMSN-CMC-FU was found to be nanoparticles with a particle size of 249.4 nm with a polydispersity of 0.429, encapsulation efficiency of 25.8 ± 5.8%, and drug loading capacity of 5.2 ± 1.2%. NMR spectra confirmed the coating of AMSN with the CMC layer. In addition, TGA, FTIR, and PXRD confirmed the drug loading inside the AMSN-CMC. Release profiles showed 100% of the drug was released from the 5-FU gel within 4 h, while AMSN-FU gel released 20.8% of the drug and AMSN-CMC-FU gel released around 55.6% after 4 h. AMSN-CMC-FU initially exhibited a 2.45-fold increase in transcorneal flux and apparent permeation of 5-FU compared to 5-FU gel, indicating a better corneal permeation. Higher bioavailability of AMSN-FU and AMSN-CMC-FU gel formulations was found compared to 5-FU gel in the ocular pharmacokinetic study with superior pharmacokinetics parameters of AMSN-CMC-FU gel. AMSN-CMC-FU showed 1.52- and 6.14-fold higher AUC0-inf in comparison to AMSN-FU and 5-FU gel, respectively. AMSN-CMC-FU gel and AMSN-FU gel were “minimally irritating” to rabbit eyes but showed minimal eye irritation potency in comparison to the 5 FU gel. Thus, the 5-FU loaded in AMSN-CMC gel could be used as a topical formulation for the treatment of ocular cancer. MDPI 2023-01-27 /pmc/articles/PMC9920178/ /pubmed/36770926 http://dx.doi.org/10.3390/molecules28031260 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alhowyan, Adel Ali
Kalam, Mohd Abul
Iqbal, Muzaffar
Raish, Mohammad
El-Toni, Ahmed M.
Alkholief, Musaed
Almomen, Aliyah A.
Alshamsan, Aws
Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title_full Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title_fullStr Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title_full_unstemmed Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title_short Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies
title_sort mesoporous silica nanoparticles coated with carboxymethyl chitosan for 5-fluorouracil ocular delivery: characterization, in vitro and in vivo studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920178/
https://www.ncbi.nlm.nih.gov/pubmed/36770926
http://dx.doi.org/10.3390/molecules28031260
work_keys_str_mv AT alhowyanadelali mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT kalammohdabul mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT iqbalmuzaffar mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT raishmohammad mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT eltoniahmedm mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT alkholiefmusaed mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT almomenaliyaha mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies
AT alshamsanaws mesoporoussilicananoparticlescoatedwithcarboxymethylchitosanfor5fluorouraciloculardeliverycharacterizationinvitroandinvivostudies